Natural resistance to hemopoietic allografts, in particular F1 hybrid resistance to parental grafts, represents one of the most puzzling immunological phenomena. The resistance is genetically specific, and is largely controlled by recessive genes located within the major histocompatibility complex (MHC). The effector mechanism, which requires natural killer (NK) cells, is poorly understood. These properties are unique, and need to be reconciled with the contemporary concepts of cellular immunology and transplantation genetics. The long-term objective of this research project is to elucidate the immunogenetic, cellular, and ultimately molecular mechanisms underlying this form of natural resistance. This application focuses on the mechanisms by which the expression of the Hh-l phenotype is regulated, particularly by MHC class I genes. Preliminary experiments demonstrate that the expression of transfected H- 2Dd gene or cDNA, but not H-2Ld gene, in H-2b/Hh-lb cells converts the cells into an Hh-lb negative phenotype, as tested in vivo. It is proposed that this model is amenable to a detailed analysis of the structural/functional requirement for the effect of Dd molecule on the Hh- lb phenotype through the use of a series of artificially constructed or naturally occurring Dd/Ld hybrid genes. These studies will determine the specificity and the potential mechanism by which the class I molecule alters the Hh-l phenotype, as opposed to the generalized effect of class I products on the susceptibility of some cells to natural killing. Further, the proposed study will test the hypothesis that the heterozygous (H-2b x H-2d) cells fail to express Hh - 1b phenotype solely due to the expression of the H - 2Dd molecule. Finally, in order to carry this project into an analysis of the biochemical events underlying the regulation of the Hh-l phenotype, an in vitro model of hybrid resistance will be developed using as effectors the adherent IL-2-activated NK cells. These studies should improve our understanding of the relationship between the classic MHC genes and the Hh system and the mechanism that underlie immune surveillance for hemopoietic neoplasms. These studies may also suggest a means of reducing bone marrow allograft failure in man.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK013969-24
Application #
2136816
Study Section
Experimental Immunology Study Section (EI)
Project Start
1977-05-01
Project End
1996-03-31
Budget Start
1994-04-01
Budget End
1995-03-31
Support Year
24
Fiscal Year
1994
Total Cost
Indirect Cost
Name
State University of New York at Buffalo
Department
Pathology
Type
Schools of Medicine
DUNS #
038633251
City
Buffalo
State
NY
Country
United States
Zip Code
14260
Motoda, K; Takata, M; Kiura, K et al. (2000) SHP-1/immunoreceptor tyrosine-based inhibition motif-independent inhibitory signalling through murine natural killer cell receptor Ly-49A in a transfected B-cell line. Immunology 100:370-7
Dagenais, S L; Nakamura, I (1997) A physical map of the mouse H2 Bat5/Db interval. Mamm Genome 8:39-41
Zheng, W P; Kiura, K; Milisauskas, V K et al. (1996) Murine NK cell allospecificity-1 is defined by inhibitory ligands. J Immunol 156:4651-5
Zheng, W; Nakamura, I (1995) Immunological screening of homologous recombination in genes that encode surface antigens. Biotechniques 18:740-2
Zheng, W P; Kiura, K; Nakamura, I (1995) Dd is the only gene that controls NK cell resistance of heterozygous H-2b/d cells. Mol Immunol 32:773-6
Basiri, H; Kiura, K; DeNardin, E G et al. (1995) Allospecificities of B6D2F1 hybrid NK cell subsets defined by Ly-49A expression. J Immunol 155:2822-32
Wroblewski, J M; Kaminsky, S G; Nakamura, I (1994) Bat-1 genes and the origin of multiple class I loci in the H-2D region. Immunogenetics 39:276-80
Milisauskas, V K; Nakamura, I (1994) The ability of H-2Dd molecule to affect natural resistance to hemopoietic allografts is an intrinsic property shared by Ddm1 but not Ld. Eur J Immunol 24:336-42
Kaminsky, S G; Yoshida, M A; Milisauskas, V K et al. (1992) Hemopoietic histocompatibility (Hh-1) phenotype and the regulation of its expression. Immunogenetics 35:117-25
Wroblewski, J M; Kaminsky, S G; Milisauskas, V K et al. (1990) The B144-H-2Db interval and the location of a mouse homologue of the human D6S81E locus. Immunogenetics 32:200-4

Showing the most recent 10 out of 13 publications